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Abstract
Background: Cervical cancer is the leading cause of cancer morbidity and mortality among women in Nepal and
Bhutan. Data on high-risk human papillomavirus (HR-HPV) infection and cervical abnormalities among Nepali and
Bhutanese women are sparse. The objectives of this study were to assess and compare the prevalence of HR-HPV
infection and cervical abnormalities among Nepali and Bhutanese women living in Jhapa District in eastern Nepal;
and examine the risk factors for HR-HPV infection and cervical abnormalities in those women.
Methods: Study participants were recruited from a women’s health camp organized by NFCC-International, a
Nepal-based non-governmental organization, in 2014. Consenting participants were administered a demographic
and health questionnaire and cervico-vaginal specimens collected. Both self-collected and clinician-collected
cervico-vaginal specimens were tested for HR-HPV infection. Cytologic exam was performed on clinician-collected
samples and cervical cytology results were categorized according to the Bethesda classification. A participant was
classified as a Bhutanese if they were either born in Bhutan or currently lived in one of the United Nations
administered Bhutanese refugee camps in Jhapa; otherwise, the participant was classified as a Nepali.
Results: Of the 647 study participants, 15.9% were Bhutanese women living in refugee camps and the overall age
(± standard deviation) was 38.8 ± 8.2 years. The prevalence of HR-HPV infection was 8.9% and abnormal cervical
cytology was 7.1% respectively, with no significant difference in HR-HPV positivity (p = 0.399) or abnormal cervical
cytology (p = 0.698) between Nepali and Bhutanese women. Compared to women whose husbands had not
migrated for employment, women whose husbands had migrated outside of the district had 3.30 times (95%
Confidence Interval [CI]: 1.13–9.64) the odds of being HR-HPV positive and women whose husbands had migrated
outside the country had 2.92 times (95% CI: 1.32–6.49) the odds of having abnormal cervical cytology.
Conclusions: HR-HPV positivity and abnormal cervical cytology were similar among Nepali and Bhutanese women.
Husbands migrating for employment within or outside the country was a significant risk factor for high-risk HPV
infection and cervical cytology, indicating the important role spousal behavior may play in HR-HPV acquisition and
cervical abnormalities among these women.
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Background
Cervical cancer is the leading cause of cancer morbidity
and mortality among women in Nepal and Bhutan. The
International Agency for Research on Cancer estimates of
cervical cancer incidence and mortality in 2012 in Nepal
were 22.4 and 18.4 per 100,000, and in Bhutan were 17.1
and 11.3 per 100,000 [1]. Cervical cancer is caused by an
infection with a “high-risk” human papillomavirus (HR-
HPV), which is sexually transmitted and is common
among sexually active individuals [2]. Limited data on the
prevalence of HR-HPV types in South Asian countries
suggest a range of 8–18% in the general female population
[3–6]. Specifically, in Nepal, our previous study among
women from a rural far-western hilly region found an HR-
HPV prevalence of 9.5% [3]. Another study among urban
and semi-urban women in the south-central plains region
of Nepal reported an HR-HPV prevalence of 8.6% [4]. To
the best of our knowledge, there are currently no studies
estimating the prevalence of HR-HPV and cervical cancer
rates among women in eastern Nepal.
The Bhutanese population consists of three major
ethnic groups: the Ngalops, the Lhotshampas, and the
Scharchops. The Ngalops are the ethnic majority, and the
Scharchops and the Lhotshampas are the two ethnic mi-
nority groups. The Lhotshampas are Bhutanese of Nepali
origin, whose ancestors migrated to Bhutan, but they
share cultural and linguistic similarities with Nepalis. A
large proportion of the Lhotshampas in Bhutan fled the
country in the early 1990s to escape ethnic and reli-
gious persecution and have been living as refugees in
eastern Nepal. In the past 8 years, over 100,000 of these
Lhotshampas Bhutanese refugees have been resettled in
western countries, most notably in the United States
[7]. Although over 100,000 have been resettled, about
20,000 still live in refugee camps and the shared socio-
cultural similarities between these Bhutanese refugees
and the Nepali population in eastern Nepal may indi-
cate a similar risk of HPV and cervical cancer in the
two groups. Currently there are no data on HR-HPV
prevalence, cervical abnormality, or cervical cancer
among Bhutanese refugee women living in Nepal or
other countries. Similarly, data on HR-HPV prevalence
and cervical abnormality among Bhutanese women in
Bhutan are limited as well. A 2014 population-based
survey conducted in women from the capital of Bhutan
found an HR-HPV prevalence of 18% [6]. However,
HPV and cervical cancer data among Bhutanese women
in other parts of the country are lacking.
Both Nepali and Bhutanese populations have geographic
and ethnic differences that may potentially influence the
risk for HPV infections and cervical cancer in these popu-
lations. Despite the exodus of a significant proportion of
Lhotshampas, or the Bhutanese of Nepali descent from
the country, they still make up about a third of Bhutan’s
population. Understanding the epidemiology of HPV and
cervical cancer abnormalities and the risk factors for
cervical cancer in the Nepali and Bhutanese populations is
important for prevention of cervical cancer. Thus, the
objectives of this study were to assess and compare the
prevalence of HR-HPV infection and cervical abnormal-
ities among Nepali and Bhutanese women living in Jhapa
District in eastern Nepal; and examine the risk factors for
HR-HPV infection and cervical abnormalities among
these women. The results of this study have relevance for
the understanding of the epidemiology of HPV and cer-
vical cancer among Nepali and Lhotshampa Bhutanese
women living in Bhutan, Nepal, and western countries.
Methods
Study setting
This study was conducted in Damak Municipality in Jhapa
District located in the Terai (lowland) region of eastern
Nepal. From the early 1990s Jhapa has been the site of five
of the seven United Nations administered refugee camps
for Bhutanese refugees in Nepal [8]. The estimated popu-
lation of the district in 2014 was 855,600. Jhapa is one of
the most developed districts in Nepal with high levels of
literacy, economic development, transportation infrastruc-
ture, and healthcare facilities [9, 10].
Participant recruitment and consent process
The study participants were recruited from a reproduct-
ive health camp organized by NFCC-International, a
Nepal-based non-governmental organization, in 2014.
Eligibility criteria for participation in the study included:
being older than 18 years; able to provide informed
consent; not menstruating; having a cervix; currently not
being pregnant. Eligible women who were interested in
participating in the study were read and explained the
informed consent form, and a written informed consent
was obtained before enrollment. Women who were not
eligible or refused to participate in the study received the
same health services as those participating in the study.
Institutional review boards from Kent State University, the
University of Alabama at Birmingham, and the Nepal
Health Research Council approved the study.
Demographic and health risk questionnaire
The participants in the study were administered a
demographic and health risk questionnaire that we
developed and used in our previous studies in Nepal.
The details of the development and the pilot testing
of the questionnaire have been previously described
[3, 11, 12]. The survey questionnaire included ques-
tions related to socioeconomic indicators, behavioral
risk, reproductive health, and migration related fac-
tors. The questionnaire was administered by trained,
native Nepali speaking research staff.
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The demographic characteristics and behavioral risk
profile assessed in the study included age, marital status,
education, nationality, number of children, previously
married or not, age at marriage, husband previously
married or not, number of life-time sexual partners, age
of sexual debut, current alcohol use, current tobacco
smoking, and whether the husband had migrated for
work inside Nepal to other districts or outside Nepal.
Assessment and classification of nationality was based
on answers to two questions: the country of birth or
whether they lived in U.N. administered refugee camps
in Nepal. A participant was considered a Bhutanese if
they either indicated that they were born in Bhutan or
currently lived in one of the refugee camps; otherwise,
the participant was classified as a Nepali.
Biological specimens and laboratory analyses
Study protocols for biological sample collection and la-
boratory analyses have been described in detail previously
[3]. During pelvic examinations trained auxiliary nurse
midwives collected cervico-vaginal specimens using the
APTIMA® Cervical Specimen Collection and Transport
(CSCT) kit (Hologic/Gen-Probe, San Diego, CA).
Cervico-vaginal samples were transported to the Hologic/
Gen-Probe, Inc. laboratory in San Diego for HPV testing.
Laboratory testing of HPV was first performed using a
generic APTIMA® HR-HPV mRNA (APTIMA® HPV)
probe (Hologic/Gen-Probe, San Diego, CA) to detect the
presence of E6/E7 mRNA from at least one of 14 different
types of HR-HPV (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52,
56, 58, 59, 66, and 68). Samples with a positive HR-HPV
test using the generic probe were then were retested with
APTIMA® HPV16 18/45 Genotype Assay to detect the
presence of HPV16 or HPV18/45 genotypes. Cervico-
vaginal samples for cervical cytology were collected in
ThinPrep® PreservCyt® medium (Hologic/Gen-Probe, San
Diego, CA) and assessed for research purposes with
results classified according to the Bethesda criteria.
Women with abnormal cervical cytology were referred to
local healthcare facilities for further evaluation, testing
and clinical follow-up.
Outcomes and risk factors of interest
HR-HPV infection and abnormal cervical cytology were
the two outcomes of interest assessed in this study. HR-
HPV infection was defined as testing positive for at least
one of the following HPV types: HPV 16, 18, 31, 33, 35,
39, 45, 51, 52, 56, 58, 59, 66, and 68. Cervical cytology was
categorized as being either “Normal” or “Abnormal” based
on the Bethesda classification system. “Normal” cervical
cytology included those samples classified as benign cellu-
lar changes, results within normal limits (WNL), atypical
squamous cells of undetermined significance (ASCUS), or
actinomycosis. “Abnormal” cervical cytology included
low-grade squamous intraepithelial lesion (LSIL), high-
grade squamous intraepithelial lesion (HSIL), squamous
cell carcinoma (SCC), atypical glandular cells of undeter-
mined Significance (AGUS), or atypical squamous cells-
cannot exclude high-grade (ASC-H).
Potential risk factors for HR-HPV infection and abnor-
mal cervical cytology assessed in this study included: age
(<45 [reproductive age] vs. ≥45 years); formal education
(none vs. some); married more than once or ‘previously
married’ (yes vs. no); husband married more than once or
‘husband previously married’ (yes vs. no); number of chil-
dren (≤1, 2, 3 or ≥4); nationality (Nepali vs. Bhutanese);
drink alcohol (yes vs. no); smoke any types of tobacco (yes
vs. no); husband migrated for work (no, yes- migrated out-
side the district, or yes-migrated outside the country).
Statistical analyses
The cervico-vaginal samples were available for HR-HPV
testing for 701 women and cervical cytology assessment
for 688 women. A total of 679 women completed the
survey questionnaires and provided information on na-
tionality. Frequency distribution and proportions were
computed for categorical variables and mean (± standard
deviation) were computed for continuous variables to
describe the demographic and risk behavioral profile for
the overall as well as the sample stratified by nationality.
Prevalence and 95% confidence interval (95% CI) for
HR-HPV infection and cervical cytology were computed
for overall and by nationality. The relationship between
independent variables described above and the two main
outcome variables (HR-HPV infection and abnormal
cervical cytology) was assessed using univariable and
multivariable logistic regression models. Crude and ad-
justed Odds Ratio (OR) and corresponding 95% CI and
p-value are reported. The multivariable logistic regres-
sion models included the following independent vari-
ables: nationality; age; formal education; and husband
migrated for work. SAS version 9.3 (SAS Institute, Cary,
NC) was used to perform all statistical analyses.
Results
Demographic characteristics and risk behavioral profile
Of the 679 women who completed the survey question-
naires, 574 (84.1%) were Nepali and 105 (15.9%) were
Bhutanese. Table 1 provides the demographic and risk
factor profile of the participants in the study. The mean
age of the sample was 38.8 (±8.2) years, with Nepali
women being significantly older than Bhutanese women
[39.5 (±8.1) vs. 35.0 (±7.8) years; p <0.001]. All the
women, except one, were currently married, widowed or
divorced, with a mean age at marriage of 19.2 (±4.0)
years. Nepali women were significantly more likely to re-
port being currently married compared to Bhutanese
women (98.3 vs. 92.8%; p = 0.001). They also reported an
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older age at marriage than Bhutanese women [19.2
(±4.0) vs. 18.0 (±3.9) years; p = 0.003]. Bhutanese women
were significantly more likely to report being married
more than once (or previously married) (8.1 vs. 1.1%; p
< 0.001). About 11% of the women reported that their
husband had been previously married. The mean num-
ber of children reported was 2.4 (±1.3). About 29% of
the women reported no formal education. There was no
significant difference between Nepali and Bhutanese
women in regards to husband being previously married,
or the level of formal education.
The mean number of life-time sexual partner reported
was 1.0, with no significant difference between two
groups. The mean age at first sexual debut was 19.3
(±4.1) years with Bhutanese women [18.2 (±4.1) years]
reporting a younger age than Nepali women [19.6 (±4.0)
years]; a difference that coincided with the difference in
the mean age of marriage. About 9% of the women re-
ported drinking alcohol and currently smoking. Bhutan-
ese women were significantly more likely to report
drinking alcohol (17.4 vs. 7.1%; p = 0.001) and current
smoking (15.1 vs. 8.0%; p = 0.033) than Nepali women.
Over a quarter of the women reported that their husbands
had migrated for work, with 21% reporting migration out-
side the country. Nepali women were almost two-times
more likely to reported spousal migration for employment
than Bhutanese women (27.4 vs. 14.7%; p = 0.04).
High-risk HPV infection and cervical cytology
In the 713 cervico-vaginal samples available for HR-HPV
testing, the prevalence of HR-HPV positivity was 8.4%
(95% CI: 6.4–10.5%). When including only the participants
who answered the nationality questions (n = 641), the
prevalence of HR-positivity was 8.9% (95% CI: 6.7–11.1%)
with no significance difference in HR-HPV prevalence
between Nepali and Bhutanese women (p = 0.399).
Among HR-HPV positive women, 41.7% were positive for
HPV 16, 18 or 45 with no significant difference between
the two groups (p = 0.850). Among HR-HPV positive
women, abnormal cervical cytology was 33.3% compared
to 5.0% among HR-HPV negative women (p < 0.001).
The prevalence of abnormal cervical cytology in the
640 satisfactory samples (out of 688 total samples) was
7.3% (95% CI: 5.3–9.4%). When including only women
with the information on nationality (n = 576), the preva-
lence of abnormal cervical cytology was 7.1% with no
significance difference between Nepali and Bhutanese
women (p = 0.698). There was also no significant differ-
ence in cervical cytology results among women with and
without the nationality information (results not shown).
HR-HPV positivity was strongly associated with abnor-
mal cervical cytology [OR = 9.6; 95% CI: 4.9–14.9].
Table 2 provides details on HR-HPV positivity and cer-
vical cytology data among Nepali and Bhutanese women.
Table 3 presents results of the univariable analyses of the
risk factors for HR-HPV positivity and abnormal cervical
cytology. In the multivariable analysis, women whose hus-
bands had migrated outside of the districts were 3.30 times
Table 1 Demographic Characteristics and Risk Behavioral Profile




679 (100.0) 574 (84.1) 105 (15.9) p- value
Age, years <0.0001
19–30 24 (3.5) 6 (1.1) 18 (17.4)
30–34 226 (33.3) 187 (32.6) 39 (37.1)
35–39 122 (18.0) 104 (18.1) 18 (17.1)
40–44 115 (16.9) 98 (17.1) 17 (16.2)
45–69 192 (28.3) 179 (31.2) 13 (12.4)
Formal education
None 219 (32.3) 179 (32.2) 40 (38.1) 0.1640
Some 460 (67.5) 395 (68.8) 65 (61.9)
Marital Status
Currently married 630 (97.5) 540 (98.4) 90 (92.8) 0.0011
OtherƗ 16 (2.5) 9 (1.6) 7 (7.2)
Previously married <0.0001
Yes 14 (2.2) 6 (1.1) 8 (8.1)
No 634 (97.8) 543 (98.9) 91 (91.9)
Husband previously married 0.8481
Yes 69 (10.6) 59 (10.7) 10 (10.1)
No 579 (89.4) 490 (89.3) 89 (89.9)
Number of children <0.0001
≤ 1 138 (21.0) 98 (17.6) 40 (40.4)
2 259 (39.4) 240 (43.0) 19 (19.2)
3 160 (24.4) 140 (25.1) 20 (20.2)
≥ 4 100 (15.2) 80 (14.4) 20 (20.2)
Drink alcohol 0.0010
Yes 55 (8.7) 38 (7.1) 17 (17.4)
No 576 (91.3) 495 (92.9) 81 (82.7)
Smoke 0.0326
Yes 60 (9.4) 45 (8.3) 15 (15.2)
No 579 (90.6) 495 (91.7) 84 (84.8)
Husband migrated for work 0.0432
No 398 (74.5) 328 (72.6) 70 (85.3)
Outside the district 24 (4.5) 21 (4.6) 3 (3.7)
Outside the country 112 (21.0) 103 (22.8) 9 (11.0)
*Not all values may add to 679 due to missing data; Number of missing values
for: Age = 0 (0%); Formal education = 0 (0%); Marital status = 33 (4.9%);
Previously married = 31 (4.6%); Husband previously married = 31 (4.6%);
Number of children = 22 (3.2%); Drink alcohol = 48 (7.1%); Smoke = 40 (5.9%);
and Husband migrated for work = 145 (21.5%)
ƗIncludes single (n = 1), divorced/separated (n = 6), or widowed (n = 9) women
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(95% CI: 1.13–9.64) as likely to be HR-HPV positive
compared to women whose husbands had not migrated
for employment (Table 4). Similarly, in the multivariable
analysis, women who husbands had migrated outside the
country for work had 2.92 times the odds of having abnor-
mal cervical cytology (95% CI: 1.32–6.49) compared to
women whose husband had not (Table 4).
Discussion
This study, conducted among a community-based sample
of Nepali and Bhutanese women living in the eastern
Terai region of Nepal, found an HR-HPV prevalence of
8.9%. The observed prevalence of HR-HPV in this study is
similar to our previous observation of a 9.6% HR-HPV
prevalence in a sample of women from the far-western
hilly region of Nepal [3]. Similar prevalence (9.9%) of HR-
HPV has been observed in the neighboring Indian state of
Uttar Pradesh [13]. The previously mentioned 2014 study
from Bhutan reported an overall HPV prevalence of 26%,
and HR-HPV prevalence of 18%, in a sample of general
population women from the capital city of Thimpu [6].
Any HPV positivity prevalence among the Lhotsampas
(Bhutanese of Nepali descent) was reported at 19.8%.
While the study did not report HR-HPV separately for the
Lhotsampa women, assuming the ratio of HR-HPV posi-
tivity to any HPV positivity in this group is similar to the
general population in Bhutan, the expected prevalence of
HR-HPV among the Lhotsampa women is likely to be
around 14%. Among Bhutanese women in our sample, the
prevalence of HR-HPV was 11%. However, the small
sample size of Bhutanese women in our study and the fact
that most of them were originally from the rural south of
Bhutan make the comparison of HR-HPV prevalence
between our sample of Lhotsampa Bhutanese women with
those from the capital of Bhutan problematic. In any case,
our study adds to the growing body of literature on the
population level data on the HR-HPV distribution among
Nepali and Bhutanese women in particular, and South-
Asian women in general, which is critical for estimating
the cervical cancer risk and targeted intervention efforts
locally, and globally among South Asian diaspora.
In addition to the HPV vaccine, primary prevention ef-
forts for HPV infection and cervical cancer focus on the
reduction of sexual exposure to HPV through behavioral
interventions for the woman and her sexual partner. In
our study, we found that almost all the women had one
life-time sexual partner—the husband—and the age of
sexual debut coincided with the age of marriage. These
results on the number of life-time sexual partners, and
the age of sexual debut and marriage for Nepali women
are consistent with other population-based data [14]. So,
for most Nepali women, the husband’s sexual behavior is
a key determinant of her risk of HPV acquisition and,
thus, the cervical cancer. This observation is supported
by our findings that the employment-related migration
of the husband within and outside Nepal is associated
with an increased risk of HR-HPV infection and cervical
abnormalities. We found that women who reported that
their husband had migrated outside the district of their
residence for employment purposes were almost five
times as likely to have an HR-HPV infection compared
to women whose husband had no history of
employment-related migration. Similarly, women who
reported their husband had migrated outside the country
for employment were almost three times as likely to
have abnormal cervical cytology compared to women
with a husband without a history of employment-related
migration. These observation have tremendous implica-
tions for the primary prevention measures for HPV
infection and cervical cancer in Nepal.
Previous studies have shown that men who are en-
gaged in professions that require travel or have migrated
for employment have been found to be at a higher-risk
of STIs including migrant workers from Nepal to India
and other countries [15–17]. Men, when away from their
wives or partners for an extended period of time, are
likely to engage in high-risk sexual behaviors, including
multiple sexual partners and sex without condoms, with
other high-risk sexual partners including commercial sex
workers. This puts a married woman in Nepal, who may
Table 2 High-risk Human Papillomavirus (HPV) Infection and
Abnormal Cervical Cytology in Samples of Nepali and
Bhutanese Women Living in Eastern Nepal
n (%)
Overall Nepali Bhutanese p- value
High-risk HPV infection (n = 641) 0.3993
No 584 (91.1) 496 (91.5) 88 (88.9)
Yes 57 (8.9) 46 (8.5) 11 (11.1)
Cervical cytologyƗ (n = 576) 0.6982
Normal 535 (92.9) 458 (92.7) 77 (93.9)
Abnormal 41 (7.1) 36 (7.3) 5 (6.1)
Cytology results in detail 0.5387
Normal
WNL 473 (82.1) 406 (82.4) 66 (80.5)
ASCUS 62 (10.8) 51 (10.3) 11 (13.4)
Abnormal
ASC-H 7 (1.2) 5 (1.0) 2 (2.4)
AGUS 10 (1.7) 10 (2.0) 0 (0.0)
LSIL 20 (3.5) 18 (3.6) 2 (2.4)
HSIL 4 (0.7) 3 (0.6) 1 (1.2)
ƗCervical cytology classification: “Normal” includes: benign cellular changes, WNL
results Within Normal Limits, ASCUS Atypical Squamous Cells of Undetermined
Significance, or actinomycosis; “Abnormal” includes: ASC-H Atypical Squamous
Cells- cannot exclude High-grade, LSIL Low-grade Squamous Intraepithelial Lesion,
HSIL High-grade Squamous Intraepithelial Lesion, AGUS Atypical Glandular Cells of
Undetermined Significance; and Squamous Cell Carcinoma (none in this sample)
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Table 3 Univariable Analyses of Risk Factors for High-risk Human Papillomavirus (HPV) Infection and Abnormal Cervical Cytology in a
Sample of Nepali and Bhutanese Women Living in Eastern Nepal
Risk Factor High-risk HPV Cervical CytologyƗ
n (%) n (%)
Total Positive Negative OR (95% CI)§ p- value Total Abnormal Normal OR (95% Cl)§ p- value
Nationality
Nepali 542 (84.6) 46 (8.5) 496 (91.5) 1.00 494 (14.2) 36 (7.3) 458 (92.7) 1.00
Bhutanese 99 (15.4) 11 (11.1) 88 (88.9) 1.35 (0.67–2.70) 0.4000 82 (85.8) 5 (6.1) 77 (93.9) 0.83 (0.31–2.17) 0.6984
Total 641 (100.0) 57 (8.9) 584 (91.1) 576 (100.0) 41 (7.1) 535 (92.9)
Age, years
45–69 175 (27.4) 9 (5.1) 166 (94.9) 1.00 151 (26.3) 10 (6.6) 141 (93.4) 1.00
19–44 464 (72.6) 48 (10.3) 416 (89.7) 2.13 (1.02–4.44) 0.0438 423 (73.7) 31 (7.3) 392 (92.7) 1.12 (0.53–2.33) 0.7725
Total 639 (100.0) 57 (8.9) 582 (91.1) 574 (100.0) 41 (7.1) 533 (92.9)
Formal education
None 185 (28.9) 15 (8.1) 170 (91.9) 1.00 162 (28.1) 9 (5.6) 153 (94.4) 1.00
Some 456 (71.1) 42 (9.2) 414 (90.8) 1.15 (0.62–2.13) 0.6570 414 (71.9) 32 (7.7) 382 (92.3) 1.42 (0.66–3.05) 0.3642
Total 641 (100.0) 57 (8.9) 584 (91.1) 576 (100.0) 41 (7.1) 535 (92.9)
Current marital Status
Other* 15 (2.5) 0 (0.0) 15 (100.0) 13 (0.0) 0 (0.0) 13 (100.0)
Married 595 (97.5) 54 (9.1) 541 (88.7) ** 535 (100.0) 41 (7.7) 494 (92.3) **
Total 610 (100.0) 54 (9.1) 556 (90.9) 548 (100.0) 41 (7.5) 507 (92.5)
Previously married
No 603 (97.7) 54 (9.0) 549 (91.0) 540 (97.6) 39 (7.2) 501 (92.8)
Yes 14 (2.3) 1 (7.1) 13 (92.9) *** 13 (2.4) 1 (7.7) 12 (92.3) ***
Total 617 (100.0) 55 (8.9) 562 (91.1) 553 (100.0) 40 (7.2) 513 (92.8)
Husband previously married
No 550 (89.1) 49 (8.9) 501 (91.1) 1.00 490 (88.9) 36 (7.3) 454 (92.7) 1.00
Yes 67 (10.9) 6 (9.0) 61 (91.0) 1.01 (0.41–2.45) 0.9900 61 (11.1) 4 (6.6) 57 (93.4) 1.13 (0.39–3.29) 0.8228
Total 617 (100.0) 55 (8.9) 562 (91.1) 551 (100.0) 40 (7.3) 511 (92.7)
Number of children
≤ 1 130 (20.9) 13 (10.0) 117 (90.0) 1.00 119 (21.2) 14 (11.8) 105 (88.2) 1.00 -
2 242 (38.8) 22 (9.1) 220 (90.9) 0.90 (0.44–1.85) 0.7746 219 (39.1) 13 (5.9) 206 (94.1) 0.47 (0.22–1.04) 0.0637
3 154 (24.7) 11 (7.1) 143 (92.9) 0.69 (0.30–1.60) 0.3907 137 (24.5) 8 (5.8) 129 (94.2) 0.47 (0.19–1.15) 0.0977
≥ 4 97 (15.6) 9 (9.3) 88 (90.7) 0.92 (0.38–2.25) 0.8557 85 (15.2) 6 (7.1) 79 (92.9) 0.57 (0.21–1.55) 0.2700
Total 623 (100.0) 55 (8.8) 568 (91.2) 560 (100.0) 41 (7.3) 519 (92.7)
Drink alcohol
No 573 (91.4) 49 (8.6) 524 (91.4) 1.00 - 515 (91.5) 34 (6.6) 481 (93.4) 1.00
Yes 54 (8.6) 6 (11.1) 48 (88.9 1.34 (0.55–3.28) 0.5258 48 (8.5) 6 (12.5) 42 (87.5) 2.02 (0.80–5.09) 0.1353
Total 627 (100.0) 55 (8.8) 572 (91.2) 563 (100.0) 40 (7.6) 523 (92.4)
Currently smoke
No 550 (90.8) 50 (9.1) 500 (90.7) 517 (90.8) 38 (7.4) 479 (92.7)
Yes 56 (9.2) 2 (3.6) 54 (96.4) *** 47 (9.2) 3 (6.4) 44 (93.6) ***
Total 606 (100.0) 52 (8.6) 554 (91.4) 564 (100.0) 41 (7.3) 523 (92.7)
Husband migrated for work
No 393 (74.6) 30 (7.6) 363 (92.4) 1.00 354 (74.2) 17 (4.8) 337 (95.2) 1.00
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only have one life-time sexual partner, at a heightened
risk for HPV and cervical cancer. With over 2 million
Nepalis (7% of the total population), primarily men [18],
engaged in migrant work within and outside of the
country annually, a significant proportion of the women
in Nepal are at an increased risk of STI infections, in-
cluding HPV infection, and cervical cancer. Thus, the
behavioral interventions for reducing HPV infection and
cervical cancer in Nepal should target husbands and
partners as they are likely the primary source of infec-
tion for the majority of the women.
We observed that over 7% of the women in the study
had abnormal cervical cytology. These women were re-
ferred to the regional hospital for further testing, diagnosis,
and follow-up treatment and care. Early detection using
the cytology smears or non-cytology based screening
methods, diagnosis, and treatment, when necessary, of
these cytologic abnormalities has been the cornerstone of
the cervical cancer prevention over the last several decades
globally. The visual inspection with acetic acid (VIA)
method is the official protocol of the government for
cervical screening in Nepal. However, only a very small
proportion of Nepali women get this cervical cancer
screening annually. A recent nation-wide survey of women
reported that only 13% of women were aware of a cervical
cancer screening test and only 5% had ever undergone a
cervical cancer screening test [19]. Lack of screening, diag-
nosis, and treatment for women with abnormal cervical
cytology continues to pose a significant barrier for cervical
cancer prevention among Nepali women. Along with
primary prevention through HPV vaccination and decreas-
ing sexual exposure to HPV infection, the provision of
Table 3 Univariable Analyses of Risk Factors for High-risk Human Papillomavirus (HPV) Infection and Abnormal Cervical Cytology in a
Sample of Nepali and Bhutanese Women Living in Eastern Nepal (Continued)
Outside the district 23 (4.4) 5 (21.7) 18 (78.3) 3.36 (1.17–9.69) 0.0248 19 (4.0) 1 (5.3) 18 (87.5) ***
Outside the country 111 (21.0) 10 (9.0) 101 (91.0) 1.20 (0.57–2.53) 0.6363 104 (21.8) 13 (12.5) 91 (94.7) 2.83 (1.33–6.05) 0.0073
Total 527 (100.0) 45 (8.5) 582 (91.5) 477 (100.0) 31 (6.5) 446 (93.5)
ƗCervical cytology classification: “Normal” includes: benign cellular changes, WNL results Within Normal Limits, ASCUS Atypical Squamous Cells of Undetermined
Significance, or actinomycosis; “Abnormal” includes: ASC-H Atypical Squamous Cells- cannot exclude High-grade, LSIL Low-grade Squamous Intraepithelial Lesion,
HSIL High-grade Squamous Intraepithelial Lesion, AGUS Atypical Glandular Cells of Undetermined Significance; and Squamous Cell Carcinoma (none in
this sample)
§OR (95% CI) = Odds Ratio (95% Confidence Interval)
*Other included single, divorced/separated, and widowed women
**OR undefined
***Too few data to estimate an OR
Table 4 Multivariable Analyses of Risk Factors for High-risk Human Papillomavirus (HPV) Infection and Abnormal Cervical Cytology in
a Sample of Nepali and Bhutanese Women Living in Eastern Nepal




aOR (95% CI)§ p- value aOR (95% CI)§ p- value
Nationality
Nepali 1.00 - 1.00 -
Bhutanese 1.31 (0.59–2.92) 0.5046 1.05 (0.34–3.19) 0.9368
Age, years
45–69 1.00 - 1.00 -
19–44 2.06 (0.84–5.04) 0.1141 0.92 (0.35–2.44) 0.8665
Formal education
None 1.00 - 1.00 -
Some 0.72 (0.35–1.49) 0.3780 0.93 (0.37–2.30) 0.8662
Husband migrated for work
No 1.00 - 1.00 -
Outside the district 3.30 (1.13–9.64) 0.0294 1.13 (0.14–9.00) 0.9112
Outside the country 1.14 (0.53–2.48) 0.7346 2.92 (1.32–6.49) 0.0084
ƗCervical cytology classification: “Normal” includes: benign cellular changes, WNL results Within Normal Limits, ASCUS Atypical Squamous Cells of Undetermined
Significance, or actinomycosis; “Abnormal” includes: ASC-H Atypical Squamous Cells- cannot exclude High-grade, LSIL Low-grade Squamous Intraepithelial Lesion,
HSIL High-grade Squamous Intraepithelial Lesion, AGUS Atypical Glandular Cells of Undetermined Significance; and Squamous Cell Carcinoma (none in
this sample)
§aOR (95% CI) = adjusted odds ratio (95% Confidence Interval); multivariable models included all the variables listed for each outcome
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screening with follow-up diagnosis and treatment is vital, if
Nepal is to reduce cervical cancer morbidity and mortality.
To the best of our knowledge, this is the first study that
has assessed the prevalence of HR-HPV infection and cer-
vical abnormalities among Bhutanese women living in Nepal
or western countries. There are about 20,000 Bhutanese
refugees still living in Nepal and about 100,000 have been
resettled in western countries, most notably in the United
States [6]. The findings of the study have implications in
cervical cancer prevention among Bhutanese women in
Bhutan, Nepal, and western countries. A small study (n =
42) conducted among resettled Bhutanese women in the
United States found that only 22.2% report ever hearing of a
Pap test and 13.9% report ever having one [20]. Moreover,
this study also reported that only one in three women per-
ceived themselves to be susceptible to cervical cancer. The
results of the current study show that Bhutanese women are
at risk of HR-HPV infection and cervical cancer. This high-
light the need for increasing awareness in this population
regarding cervical cancer as a potential health risk, its cause
and the available primary and secondary prevention modal-
ities as first steps towards cervical cancer prevention efforts.
The study results should be interpreted in the context
of the strengths and limitations of the study. The sample
for the study was recruited from a health camp as a con-
venience sample. Thus, the Nepali women in the study
may not be a representative sample of all the Nepali
women living in Jhapa district. Similarly, the Bhutanese
women in the study may not a representative sample of
the Bhutanese refugee women in the camps. Moreover,
the majority of Bhutanese refugees in Nepal have been
resettled in western countries, thus, those still remaining
in Nepal and participating in the study may suffer from
selection bias. However, as the first study among this
group to assess HR-HPV infection and cervical abnor-
malities, the results provide important preliminary infor-
mation on the cervical cancer risk in this population. As
a cross-sectional study, we measured the prevalence of
HR-HPV infection, not the life-time exposure or persist-
ence of HPV, which are better predictors of cervical pre-
cancerous lesions. However, HPV prevalence data is still
a useful proxy for assessing cervical cancer risk, when
longitudinal data are not available. Also, our study used
an mRNA based test to detect the presence of HR-HPV,
a test that detects the expression of genes related to E6/
E7. Most population-based studies of HPV prevalence
have relied on DNA-based techniques to detect the pres-
ence of the HR-HPV virus genome. Thus, the prevalence
observed in our study may not be directly comparable to
studies using DNA-based techniques.
Conclusions
The prevalence of HR-HPV and abnormal cervical cytology
among Nepali and Bhutanese women in eastern Nepal
were similar to the prevalence observed in our previous
study conducted in far-western Nepal [3]. While the sexual
risk behaviors reported by the women indicated them as
being a low-risk for HPV infection, husband’s migration
outside the district or the country was a significant risk
factor for high-risk HPV infection and cervical cytology.
Employment-related migration is a surrogate for high-risk
sexual behavior among men. These findings highlight the
important role husband’s sexual behavior plays in HPV in-
fection and cervical cancer risk among Nepali and Nepali
women. Since the HPV vaccine is not widely available and
used in Nepal yet, and millions of women are too old to be
vaccinated, an important prevention effort for cervical can-
cer needs to focus on reducing high-risk sexual behaviors
among men. The low level of knowledge regarding cervical
cancer cause and prevention methods observed among
Nepali and Bhutanese-Nepali women [12, 20] highlight the
need for health education to increase the knowledge and
awareness of the risk factors for HPV infection and cervical
cancer risk.
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